QUALCOMM has staged one of its sharpest weekly recoveries on record, up 27% to close at $248.82 — yet the analyst community, with most targets clustered between $150 and $200, is still pointing at a stock trading well above their numbers.
The price move reverses the retreat documented in last week's note. Seven days ago the stock was back near $195, surrendering post-earnings gains. This week it reclaimed all of that and then some. The 67% one-month gain now looks emphatic rather than tentative. Peers confirm the sector is broadly surging: HIMX added 18% on the week and INTC gained 14%, while the highest-correlation name in the peer set — MediaTek (2454 on TSEC) — rose 25%. QUALCOMM is keeping pace with the chip rally, not leading it.
Short sellers are sitting this rally out entirely. Short interest barely moved — up less than 1% on the week to 3.66% of the free float — continuing a pattern that began after April's blowout earnings print. The contrast with late April is stark: at that point, close to 55 million shares were short; today the figure is under 40 million. Borrow conditions give shorts no reason to rush back in either. Cost to borrow is negligible at 0.46%, and availability is extraordinarily loose at over 2,500% of short interest — meaning for every share currently borrowed, there are roughly 25 more available. The lending market is wide open; there is simply no pressure on existing shorts to cover, and no friction discouraging new ones.
Options traders are showing a modest defensive lean, but nothing alarming. The put/call ratio has drifted up to 0.754 from a recent average near 0.68 — about 1.4 standard deviations above that mean. That's elevated but well short of the defensive extremes near 1.09 seen at the 52-week high. The drift in the PCR tracks the price rally: some investors are buying puts to hedge gains, not expressing a directional bearish conviction.
The Street's reaction to the move is the most interesting tension heading into next week. Almost every analyst raised their target after the April 29 earnings beat — JPMorgan lifted to $160, UBS to $170, TD Cowen to $200 — but even the most optimistic published target (Tigress Financial at $280, raised from $270 on May 8) is only marginally above where the stock now trades. The consensus mean sits near $178, roughly 28% below the current price. That disconnect matters. The analyst consensus is technically rated "buy," but most of the upgrades and target increases happened when the stock was in the $140–$160 range. Daiwa Capital made the most notable move, upgrading to Outperform and lifting its target from $140 to $225 on May 8 — still 10% below the current level.
The bull case rests on Qualcomm's positioning in AI-enabled edge devices, automotive silicon, and IoT — diversification away from the smartphone cycle that has historically been its weakness. The bear case is harder to dismiss at current prices: EPS momentum scores rank in the bottom quintile over both 30 and 90 days, meaning near-term earnings revisions have been running negative even as the stock rips. The analyst recommendation divergence score ranks at the 98th percentile — an unusually wide spread between optimists and sceptics — which historically signals that the Street has not yet reached a settled view on the name.
The next scheduled earnings date is June 24. The last print delivered a 19.7% single-day gain and a 28% five-day move. With the stock already up 67% over the past month and most analyst targets now sitting below the market price, the June print lands in a context where execution against guidance carries considerably more weight than the headline beat-or-miss.
See the live data behind this article on ORTEX.
Open QCOM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
